Provided by Tiger Fintech (Singapore) Pte. Ltd.

Taysha Gene Therapies, Inc.

2.84
-0.0400-1.39%
Volume:6.67M
Turnover:19.16M
Market Cap:744.08M
PE:-8.50
High:3.08
Open:2.96
Low:2.79
Close:2.88
Loading ...

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
06 Jun

Paul B. Manning, 10% Owner, Reports Acquisition of Common Shares in Taysha Gene Therapies Inc

Reuters
·
04 Jun

BRIEF-Taysha Gene Therapies Announces Details For Oral Presentations

Reuters
·
04 Jun

Taysha Gene Therapies Announces Details for Oral Presentations at the 2025 Irsf Rett Syndrome Scientific Meeting Reviewing Recent Updates From the Tsha-102 Clinical Program

THOMSON REUTERS
·
04 Jun

Taysha Gene Therapies Inc. Conducted Annual Stockholders Meeting

Reuters
·
03 Jun

Taysha Gene Therapies price target raised to $11 from $9 at Canaccord

TIPRANKS
·
03 Jun

Taysha Gene Therapies Price Target Raised to $8.00/Share From $6.00 by Needham

Dow Jones
·
03 Jun

Taysha Gene Therapies (TSHA) Gets a Buy from Piper Sandler

TIPRANKS
·
02 Jun

Positive Outlook for Taysha Gene Therapies: Strong Study Design and Promising Data Support Buy Rating

TIPRANKS
·
30 May

Taysha Gene Therapies Announces Major Stock Offering

TIPRANKS
·
30 May

Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Court Blocks Trump Tariffs

MT Newswires Live
·
29 May

Taysha Gene Therapies Is Maintained at Buy by Chardan Capital

Dow Jones
·
29 May

Taysha Gene Therapies 46.9M share Spot Secondary priced at $2.75

TIPRANKS
·
29 May

BRIEF-Taysha Gene Prices Public Offering Of 46.9 Mln Shares At $2.75 Each

Reuters
·
29 May

Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
29 May

Taysha Gene Therapies Inc - Prices Public Offering of 46.9 Mln Shares at $2.75 Each

THOMSON REUTERS
·
29 May

Taysha Gene Therapies Announces Pivotal Trial Design for TSHA-102

TIPRANKS
·
29 May

Taysha Gene Therapies announces common stock offering, no amount given

TIPRANKS
·
29 May

Taysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

THOMSON REUTERS
·
29 May

Taysha Gene Therapies Inc - FDA Advises Submission of Pivotal Part B Trial Protocol as Ind Amendment

THOMSON REUTERS
·
29 May